Barrow, Hanley, Mewhinney & Strauss’s Novanta NOVT Stock Holding History
Bought
Maintained
Sold
Other funds holding NOVT
VPM
VCM
CCA
WA
GCM
Barrow, Hanley, Mewhinney & Strauss's NOVT Position: Q1 2026 in Review
Barrow, Hanley, Mewhinney & Strauss increased its Novanta (NOVT) stake by 19% in Q1 2026, buying an estimated $8.51M and bringing the position to 411,514 shares worth $48.6M. The position accounts for 0.16% of the portfolio, ranked #107.
Barrow, Hanley, Mewhinney & Strauss first reported a position in NOVT in Q3 2016 and has held it in 5 quarters since. 330 funds tracked by Wall St. Rank hold NOVT as of Q1 2026.
- Barrow, Hanley, Mewhinney & Strauss held 411,514 shares of Novanta worth $48.6M as of Q1 2026.
- Barrow, Hanley, Mewhinney & Strauss bought 64,881 Novanta shares in Q1 2026, an estimated $8.51M.
- Novanta made up 0.16% of Barrow, Hanley, Mewhinney & Strauss's portfolio in Q1 2026, its #107 holding.
- Barrow, Hanley, Mewhinney & Strauss first reported a position in Novanta in Q3 2016 and has held it in 5 quarters since.
- 330 funds tracked by Wall St. Rank held Novanta as of Q1 2026.
Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q1 2026, filed 13 May 2026.